Stock Groups

J&J Earnings Beat, Revenue Misses In Q4 -Breaking

by Mike Robinson

[ad_1]

© Reuters. J&J Earnings Beat, Revenue Misses In Q4

Investing.com – J&J reported on Tuesday fourth quarter that beat analysts’ forecasts and revenue that fell short of expectations.

J&J announced earnings per share of $2.13 on revenue of $24.8B. Investing.com polled analysts and predicted EPS at $2.12 for revenue of $25.28B.

J&J shares are down 4% from the beginning of the year, still down 9.42% from its 52 week high of $179.92 set on August 20, 2021. They are outperforming the S&P 500 which is down 7.47% from the start of the year.

J&J follows other major Healthcare sector earnings this month

J&J’s report follows an earnings beat by UnitedHealth on January 19, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.

Intuitive Surgery beat all expectations with a fourth quarter earnings per share of $1.3 on $1.55B in revenue, as compared to $1.28 for $1.52B revenue.

You can keep up to date on the latest earnings reports at www.investors.com Investing.com’s earnings calendar

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from relying on data including charts, buy/sell signals, and quotes. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]